Recombinant CD22 (Epratuzumab Biosimilar) antibody
This Human Monoclonal antibody specifically detects CD22 (Epratuzumab Biosimilar) in . It exhibits reactivity toward Human.
Catalog No. ABIN7666127
Quick Overview for Recombinant CD22 (Epratuzumab Biosimilar) antibody (ABIN7666127)
Target
CD22 (Epratuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This CD22 (Epratuzumab Biosimilar) antibody is un-conjugated
Application
Please inquire
-
-
Expression System
- CHO Cells
-
Purpose
- CD22 antibody (Epratuzumab biosimilar)
-
Purity
- ≥95 % (SDS-PAGE&SEC)
-
Isotype
- IgG1
-
-
anti-CD22 (Epratuzumab Biosimilar) antibody
Reactivity: Human, Cynomolgus, Rhesus Monkey BP, FACS, IP Host: Rabbit Chimeric hL22 unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Storage Comment
- Please store the product under the recommended conditions in the the instructions.
-
-
- CD22 (Epratuzumab Biosimilar)
-
Alternative Name
- Epratuzumab biosimilar
-
Target Type
- Biosimilar
-
Background
- Epratuzumab | CD22
-
Gene ID
- 933
-
UniProt
- P20273
Target
-
You are here:
